English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCanadian Cardiovascular Society consensus statement published in the Canadian Journal of Cardiology paves the way for refining treatment and providing individualized care
Tag: Drug Therapy
Scientists build on artificial intelligence to create next-generation gastric acid treatment
Nagoya University researchers used AI to design and synthesize a new, highly effective gastric acid inhibitor, demonstrating the potential of AI in pharmaceutical development.
Anti-anxiety drug may improve brain cancer survival chances
A new research study shows that cerebrospinal fluid reduces current treatment efficacy in brain cancer and identifies new therapeutic opportunities.
Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus
New study finds everolimus benefits high-risk kidney cancer patients
Collaborative and creative policies needed to maximize psychedelics’ therapeutic potential
Research supports the promise of psychedelics in treating conditions like depression and post-traumatic stress disorder, but the future regulatory landscape for these drugs remains unclear. Experts from Baylor College of Medicine, the University of Pennsylvania, American University and Harvard Law School call for creativity and collaboration at the federal and state levels in developing policies for the use and oversight of psychedelics and a commitment to developing a strong evidence base for efficacy and safety.
Over half of top selling Medicare drugs have low added therapeutic benefit
Brand-name drugs cost two to three times more in the U.S. than in other countries, but many of the top-selling brand name drugs may provide little added therapeutic benefit. A new study led by researchers at Brigham and Women’s Hospital, a founding member of Mass General Brigham, used public Medicare data to identify the 50 highest-selling brand-name drugs in 2020.
Degrading modified proteins could treat Alzheimer’s, other ‘undruggable’ diseases
A new technique that targets and breaks apart certain proteins — rather than just interfering with them — may offer a pathway toward treatment of Alzheimer’s disease. Researchers reporting in ACS Central Science have designed a compound that breaks down a protein closely associated with the disease.
New hope for treatment of rare metabolic disease
X-linked adrenoleukodystrophy (X-ALD) is the most common of a group of around 50 rare diseases of the white matter of the brain, the so-called leukodystrophies.
A step towards precision oncology for patients with metastatic urothelial carcinoma
Dr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University Hospital Bonn (UKB), was awarded the C. E. Alken Prize in recognition of his outstanding scientific uro-oncological work.
Researchers map deep brain stimulation target for Alzheimer’s disease
Alzheimer’s disease (AD) is the fifth leading cause of death in adults over 65 years old. While many potential treatments for the neurodegenerative disease focus on developing drugs to target key culprits, a relatively new approach aims to more directly treat the brain.
Psychiatrists disagree with U.S. policy on psychoactive drugs
A new national survey reveals considerable differences between psychiatrists’ perceptions about the safety and therapeutic value of certain psychoactive drugs and how those same drugs are categorized under U.S. policy.
The drug gabapentin may boost functional recovery after a stroke
The drug gabapentin, currently prescribed to control seizures and reduce nerve pain, may enhance recovery of movement after a stroke by helping neurons on the undamaged side of the brain take up the signaling work of lost cells, new research in mice suggests.
“Digital twins” – an aid to give individual patients the right treatment at the right time
An international team of researchers have developed advanced computer models, or “digital twins”, of diseases, with the goal of improving diagnosis and treatment.
Research reveals drug targets for memory enhancement
Bristol-led research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances in the treatment of a broad spectrum of brain disorders.